Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2026 Mar;17(5):e70264.
doi: 10.1111/1759-7714.70264.

Disruption of Radiological Surveillance Following a Global Health Crisis in Resected Lung Cancer

Collaborators, Affiliations
Observational Study

Disruption of Radiological Surveillance Following a Global Health Crisis in Resected Lung Cancer

Álvaro Fuentes-Martín et al. Thorac Cancer. 2026 Mar.

Abstract

Objectives: Radiological surveillance after curative-intent lung cancer resection is essential for early detection of recurrence and second primary tumors. Large-scale health emergencies can compromise oncologic follow-up. This study quantifies the impact of a health crisis on radiological surveillance in a national cohort of resected lung cancer patients.

Methods: A time-segmented observational cohort study was performed using data from the prospective, multicenter GEVATS registry. Surveillance density (CT/month) was evaluated across three predefined periods: pre-pandemic (baseline), state of alarm (maximum healthcare restrictions), and post-alarm (recovery phase). The population at risk was updated for each period. Subgroup analyses during the post-alarm phase assessed prioritization according to neoadjuvant treatment, pathological stage, age, and comorbidity.

Results: Among 2382 eligible patients, surveillance density declined progressively from the pre-pandemic period (0.157 ± 0.079 CT/month) to the state of alarm (0.098 ± 0.071 CT/month). In the post-alarm phase, density dropped sharply to 0.023 ± 0.018 CT/month (equivalent to one CT every 3.6 years), representing a 76.5% reduction compared with the state-of-alarm period (p < 0.001). This under-surveillance was generalized, with no significant differences by pathological stage (p = 0.084), age (p = 0.564), or comorbidity (p = 0.872). Only prior neoadjuvant therapy was associated with a slightly higher density (p = 0.040).

Conclusions: A prolonged health crisis resulted in a profound and persistent reduction in radiological surveillance after lung cancer resection, without evidence of risk-based prioritization. These findings support the need for contingency frameworks within clinical guidelines to preserve continuity of oncologic follow-up during future health emergencies.

Keywords: follow‐up studies; health services; lung neoplasms; thoracic surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flowchart of patient selection for the analysis of the total number of patients in the GEVATS database.
FIGURE 2
FIGURE 2
Mean density of computed tomography scans per month (CT/month) during postoperative follow‐up of patients with resected lung cancer across the three defined study periods. Red dashed lines indicate the surveillance density recommended by clinical guidelines for each period: 0.167 CT/month (one CT every 6 months) during the pre‐pandemic phase, and 0.083 CT/month (one annual CT) during the state‐of‐alarm and post‐alarm periods. Error bars represent the standard error of the mean.

References

    1. Philip B., Jain A., Ramesh P., et al., “Follow‐Up and Surveillance Post Lung Cancer Surgery: A Narrative Review,” Video‐Assisted Thoracic Surgery 8 (2023): 7, 10.21037/vats-22-28. - DOI
    1. Subotic D., Van Schil P., and Grigoriu B., “Optimising Treatment for Post‐Operative Lung Cancer Recurrence,” European Respiratory Journal 47, no. 2 (2016): 374–378, 10.1183/13993003.01490-2015. - DOI - PubMed
    1. Colt H. G., Murgu S. D., Korst R. J., Slatore C. G., Unger M., and Quadrelli S., “Follow‐Up and Surveillance of the Patient With Lung Cancer After Curative‐Intent Therapy: Diagnosis and Management of Lung Cancer, 3rd Ed: American College of Chest Physicians Evidence‐Based Clinical Practice Guidelines,” Chest 143, no. Suppl 5 (2013): e437S–e454S, 10.1378/chest.12-2365. - DOI - PubMed
    1. Ettinger D. S., Wood D. E., Aisner D. L., et al., “Non‐Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology,” Journal of the National Comprehensive Cancer Network 15, no. 4 (2017): 504–535, 10.6004/jnccn.2017.0050. - DOI - PubMed
    1. Schneider B. J., Ismaila N., Aerts J., et al., “Lung Cancer Surveillance After Definitive Curative‐Intent Therapy: ASCO Guideline,” Journal of Clinical Oncology 38, no. 7 (2020): 753–766, 10.1200/JCO.19.02748. - DOI - PubMed

Publication types